Rheumatology Network interviewed James Woody, MD, PhD, to understand the key findings of the Phase 2b clinical trial, “Repurposing Anti-TNF for Treating Dupuytren’s Disease (RIDD).” During the study, investigators repurposed adalimumab to treat this disabling condition that causes fingers to curl irreversibly into the palm. Woody is the CEO of 180 Life Sciences. James Woody, MD, PhD: [Dupuytren’s […]

If you walk into The Kremlin, you can be hit by the warm, welcoming smell of cannabis—just make sure you’re in the Bay Area around harvest time, not Moscow. The Kremlin is Unrivaled Brands’ cultivation facility in Oakland, Calif., where the vertically integrated multi-state operator recently harvested its first crop. The company launched The Kremlin in September. […]

In preparing for this year’s annual outlook issue (published in December), Life Science Leader posed a variety of questions to biopharmaceutical executives. Unfortunately, not all the responses could be squeezed into the annual outlook print edition, so we decided to share them here. Don’t miss out on all the other knowledge and wisdom provided by the more […]